The Business Of Biotech Podcast
-
Funding Tips And Moving From R&D To Commercial With Madrigal Pharmaceuticals' Mardi Dier
11/5/2025
On this week's episode of the Business of Biotech, Mardi Dier, CFO at Madrigal Pharmaceuticals, talks about building relationships in investment banking and investor relations before moving into business development and becoming a chief financial officer.
-
Emerging From Stealth With Vima Therapeutics' Bernard Ravina, M.D.
10/31/2025
On this week's episode of the Business of Biotech, we're speaking with Bernard Ravina, M.D., CEO at Vima Therapeutics, a company that emerged from stealth in May with $60 million Series A financing to develop an oral candidate for dystonia, a movement disorder.
-
BoB in South Florida: Rich Daly, Catalyst Pharmaceuticals
10/24/2025
On this week's episode — the last of our four-part series focused on South Florida — we catch up with Rich Daly, CEO at Catalyst Pharmaceuticals, a member of Life Science Leader's editorial advisory board and Miami-based location host for our in-person series.
-
BoB In South Florida: Anthony Japour, M.D., iTolerance
10/16/2025
On this week's episode of the Business of Biotech, Anthony Japour, M.D., CEO at iTolerance, talks about his work as a physician treating infectious diseases, his CEO role in diagnostics at the height of the COVID-19 pandemic, what he learned working as a medical director at a large CRO, and iTolerance's work toward a cure for Type 1 diabetes that doesn't require chronic immunosuppression.
-
BoB In South Florida: Daniel Teper, NAYA Therapeutics
10/9/2025
In this week's episode of the Business of Biotech -- part two in a four-part series recorded in-person at Catalyst Pharmaceuticals' Miami headquarters -- we're speaking with Daniel Teper, an entrepreneur and most recently, founder and CEO at NAYA Therapeutics.
-
BoB In South Florida: Raquel Cabo, Miami Biotech Collective
10/2/2025
The Business of Biotech is on location in Miami this week! For the first episode in this four-part series on the biotech scene in South Florida, Raquel Cabo, Founder and President of the Miami Biotech Collective, talks about her experiences as a member of the founding team at Ovid Therapeutics, why South Florida needed an organization to connect regional drug developers, and more.
-
The Business Case For Health Economics And Outcomes Research With ISPOR's Rob Abbott
9/26/2025
On this week's episode of the Business of Biotech, Rob Abbott, CEO of ISPOR, explains how startup and early-stage clinical drug development companies benefit from conducting health economics and outcomes research (HEOR), and not just with patients and commercial payers.
-
Cannabinoid And Psychedelic Combinations With Incannex Healthcare's Joel Latham
9/19/2025
On this week's Business Of Biotech episode, Joel Latham, President and CEO at Incannex Healthcare, talks about developing cannabinoid and psychedelic combination therapies for conditions as diverse as sleep apnea, rheumatoid arthritis, and generalized anxiety disorder.
-
Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small
9/11/2025
On this week's Business Of Biotech episode, Lyle Small, Founder and CEO at Lahjavida, a dye drug conjugate start-up, talks about creating the famous color-changing technology that turned the mountains blue on cold Coors Light beer cans, to launching a dye-drug conjugate startup developing targeted cancer therapies.
-
Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D.
9/4/2025
On the Business of Biotech this week, Sahir Ali, Ph.D., founder and general partner at Modi Ventures, a family office investing at the intersection of technology and biology, talks about adapting the Markowitz model to improve returns and balance risk, his concept of the "biostack" for making direct investments into life sciences companies, and the revolutionary potential of scientific super intelligence.